Hsien‐Yi Wang
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
-
- Natural Antidiabetic Agents Studies
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
Papers in
-
- Dialysis and Renal Disease Management 2
- Acute Kidney Injury Research 2
- Chronic Kidney Disease and Diabetes 1
- Co-authors
- Wei‐Chih Kan (14 shared papers)Tsair‐Wei Chien (8 shared papers)Jui‐Yi Chen (5 shared papers)Jiunn‐Jye Chuu (6 shared papers)Shih‐Bin Su (9 shared papers)Min‐Hsiang Chuang (3 shared papers)Tain‐Junn Cheng (4 shared papers)Vin‐Cent Wu (3 shared papers)
In The Last Decade
Hsien‐Yi Wang
33 papers receiving 781 citations
Hsien‐Yi Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Nephrology 74
- Endocrinology, Diabetes and Metabolism 148
- Obstetrics and Gynecology 51
- Drug Discovery 1
- Pharmacology 81
Countries citing papers authored by Hsien‐Yi Wang
This map shows the geographic impact of Hsien‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsien‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsien‐Yi Wang more than expected).
Fields of papers citing papers by Hsien‐Yi Wang
This network shows the impact of papers produced by Hsien‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsien‐Yi Wang. The network helps show where Hsien‐Yi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsien‐Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 96 | |
| 2 | 2016 | 91 | |
| 3 | Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes Hit paper breakdown → | 2024 | 80 |
| 4 | 2013 | 60 | |
| 5 | 2016 | 48 | |
| 6 | 2014 | 47 | |
| 7 | 2024 | 47 | |
| 8 | 2019 | 39 | |
| 9 | 2012 | 36 | |
| 10 | 2018 | 32 | |
| 11 | 2012 | 31 | |
| 12 | 2019 | 24 | |
| 13 | 2012 | 22 | |
| 14 | 2018 | 19 | |
| 15 | 2014 | 16 | |
| 16 | 2013 | 15 | |
| 17 | 2013 | 13 | |
| 18 | 2012 | 11 | |
| 19 | 2011 | 10 | |
| 20 | 2024 | 9 |
About Hsien‐Yi Wang
Hsien‐Yi Wang is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Pharmacology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 804 indexed citations. Recurring topics across this work include Fungal Biology and Applications (3 papers), Dialysis and Renal Disease Management (2 papers), Data-Driven Disease Surveillance (2 papers), Acute Kidney Injury Research (2 papers), Medicinal Plants and Bioactive Compounds (2 papers), Advanced Data Storage Technologies (1 paper), Chronic Kidney Disease and Diabetes (1 paper) and Aluminum toxicity and tolerance in plants and animals (1 paper). The work is most often cited by research in Nephrology (74 citations), Endocrinology, Diabetes and Metabolism (148 citations), Obstetrics and Gynecology (51 citations), Drug Discovery (1 citation) and Pharmacology (81 citations). Hsien‐Yi Wang has collaborated with scholars based in Taiwan, Hong Kong and Hungary. Frequent co-authors include Wei‐Chih Kan, Tsair‐Wei Chien, Jui‐Yi Chen, Jiunn‐Jye Chuu, Shih‐Bin Su, Min‐Hsiang Chuang, Tain‐Junn Cheng, Vin‐Cent Wu, Yihua Lu and Chin‐Chen Chu. Their work appears in journals such as Medicine, International Journal of Molecular Sciences, BMJ Open, The Journal of Clinical Endocrinology & Metabolism and Bioscience Biotechnology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.